Soleus Capital Master Fund, L.P. 13D and 13G filings for Surmodics, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2025-01-22 5:15 pm Purchase | 2025-01-21 | 13G | Surmodics, Inc. SRDX | Soleus Capital Master Fund, L.P. | 739,060 5.200% | 101,362 (+15.89%) | Filing |
| 2024-11-14 3:36 pm Sale | 2024-09-30 | 13G | Surmodics, Inc. SRDX | Soleus Capital Master Fund, L.P. | 637,698 4.500% | -134,002 (-17.36%) | Filing |
| 2024-02-02 09:53 am Sale | 2023-12-31 | 13G | Surmodics, Inc. SRDX | Soleus Capital Master Fund, L.P. | 771,700 5.400% | -3,611 (-0.47%) | Filing |
| 2023-02-14 08:16 am Purchase | 2022-12-31 | 13G | Surmodics, Inc. SRDX | Soleus Capital Master Fund, L.P. | 775,311 5.500% | 61,347 (+8.59%) | Filing |
| 2022-09-02 10:21 am Purchase | 2022-08-31 | 13G | Surmodics, Inc. SRDX | Soleus Capital Master Fund, L.P. | 713,964 5.100% | 713,964 (New Position) | Filing |